ATE262907T1 - Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison - Google Patents

Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison

Info

Publication number
ATE262907T1
ATE262907T1 AT96902557T AT96902557T ATE262907T1 AT E262907 T1 ATE262907 T1 AT E262907T1 AT 96902557 T AT96902557 T AT 96902557T AT 96902557 T AT96902557 T AT 96902557T AT E262907 T1 ATE262907 T1 AT E262907T1
Authority
AT
Austria
Prior art keywords
hydrocortisone
pharmaceutical preparation
topical application
application containing
containing acyclovir
Prior art date
Application number
AT96902557T
Other languages
English (en)
Inventor
Johan Georg Harmenberg
Ann Harriet Marg Kristofferson
Original Assignee
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medivir Ab filed Critical Medivir Ab
Application granted granted Critical
Publication of ATE262907T1 publication Critical patent/ATE262907T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52Purines, e.g. adenine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0014Skin, i.e. galenical aspects of topical compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/58Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Dermatology (AREA)
  • Biotechnology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
AT96902557T 1995-02-06 1996-02-02 Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison ATE262907T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9500114 1995-02-06
PCT/SE1996/000124 WO1996024355A1 (en) 1995-02-06 1996-02-02 Novel pharmaceutical combination

Publications (1)

Publication Number Publication Date
ATE262907T1 true ATE262907T1 (de) 2004-04-15

Family

ID=20396821

Family Applications (2)

Application Number Title Priority Date Filing Date
AT03028943T ATE421358T1 (de) 1995-02-06 1996-02-02 Pharmazeutische formulierung zur topischen anwendung enthaltend eine antivirale substanz und ein glucocorticoid
AT96902557T ATE262907T1 (de) 1995-02-06 1996-02-02 Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT03028943T ATE421358T1 (de) 1995-02-06 1996-02-02 Pharmazeutische formulierung zur topischen anwendung enthaltend eine antivirale substanz und ein glucocorticoid

Country Status (30)

Country Link
US (2) USRE39264E1 (de)
EP (2) EP0809498B1 (de)
JP (2) JP4260220B2 (de)
KR (1) KR100431042B1 (de)
CN (1) CN1131034C (de)
AR (1) AR002030A1 (de)
AT (2) ATE421358T1 (de)
AU (1) AU716809B2 (de)
CA (1) CA2211389C (de)
DE (3) DE69632034T2 (de)
DK (1) DK0809498T3 (de)
DZ (1) DZ1966A1 (de)
ES (1) ES2214528T3 (de)
FI (1) FI119415B (de)
FR (1) FR10C0038I2 (de)
HK (1) HK1004368A1 (de)
HR (1) HRP960034B1 (de)
IL (1) IL116913A0 (de)
MA (1) MA23800A1 (de)
MY (1) MY119365A (de)
NO (1) NO314220B1 (de)
NZ (1) NZ301407A (de)
PT (1) PT809498E (de)
SA (1) SA96160590B1 (de)
SI (1) SI0809498T1 (de)
TN (1) TNSN96024A1 (de)
TW (1) TW438585B (de)
WO (1) WO1996024355A1 (de)
YU (1) YU49477B (de)
ZA (1) ZA96527B (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9601544D0 (en) * 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals
IT1287114B1 (it) * 1996-10-31 1998-08-04 Recordati Chem Pharm Composizioni farmaceutiche antierpetiche per applicatori topici, contenenti aciclovir
SE9803929D0 (sv) * 1998-11-18 1998-11-18 Medivir Ab Antiviral formulation
US7223387B2 (en) 1998-11-18 2007-05-29 Medivir Ab Antiviral formulations comprising propylene glycol and an isopropyl alkanoic acid ester
US7655252B2 (en) 1999-04-28 2010-02-02 The Regents Of The University Of Michigan Antimicrobial nanoemulsion compositions and methods
US7767216B2 (en) * 1999-04-28 2010-08-03 The Regents Of The University Of Michigan Antimicrobial compositions and methods of use
FR2837102B1 (fr) * 2002-03-18 2004-10-08 Palbian Snc Composition a l'etat de gel aqueux, procede de fabrication et utilisation pour la fabrication d'un medicament, notamment antiherpetique
US20040023935A1 (en) * 2002-08-02 2004-02-05 Dey, L.P. Inhalation compositions, methods of use thereof, and process for preparation of same
US20040109826A1 (en) * 2002-12-06 2004-06-10 Dey, L.P. Stabilized albuterol compositions and method of preparation thereof
US20050208083A1 (en) 2003-06-04 2005-09-22 Nanobio Corporation Compositions for inactivating pathogenic microorganisms, methods of making the compositons, and methods of use thereof
AR045536A1 (es) * 2003-08-29 2005-11-02 Ranbaxy Lab Ltd Inhibidores de la fosfodiesterasa tipo -iv
EP1694655A2 (de) * 2003-11-26 2006-08-30 Ranbaxy Laboratories Limited Phosphodiesteraseinhibitoren
US7618950B2 (en) * 2004-07-07 2009-11-17 Arigen Pharmaceuticals, Inc. Method for treatment and prevention of herpes zoster by topical application
CL2006000697A1 (es) * 2005-03-30 2008-05-09 Novartis Ag Uso de famciclovir para el tratamiento del herpes labial recurrente.
EP1871349A1 (de) * 2005-04-11 2008-01-02 Nanobio Corporation Quartäre ammoniumhalogenide zur behandlung von infektionskrankheiten
CA2618974C (en) * 2005-08-09 2014-01-28 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
US7915286B2 (en) 2005-09-16 2011-03-29 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
US7797337B2 (en) * 2005-09-29 2010-09-14 Scenera Technologies, Llc Methods, systems, and computer program products for automatically associating data with a resource as metadata based on a characteristic of the resource
US20090221664A1 (en) 2005-10-19 2009-09-03 Abhijit Ray Pharmaceutical compositions of muscarinic receptor antagonists
EP1948167A1 (de) * 2005-10-19 2008-07-30 Ranbaxy Laboratories, Ltd. Zusammensetzungen von phosphodiesterase-typ-iv-hemmern
FR2900577B1 (fr) * 2006-05-04 2008-09-12 Goemar Lab Sa Nouveaux medicaments pour les traitements contre le virus de l'herpes
CA2664247A1 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Inhibitors of phosphodiesterase type-iv
WO2008035316A2 (en) * 2006-09-22 2008-03-27 Ranbaxy Laboratories Limited Phosphodiesterase inhibitors
US20080207659A1 (en) * 2007-02-15 2008-08-28 Asit Kumar Chakraborti Inhibitors of phosphodiesterase type 4
US20110130403A1 (en) * 2007-03-14 2011-06-02 Ranbaxy Laboratories Limited Pyrazolo [3, 4-b] pyridine derivatives as phosphodiesterase inhibitors
MX2009009793A (es) * 2007-03-14 2009-10-16 Ranbaxy Lab Ltd Derivados de pirazolo (3,4-b) piridina como inhibidores de fosfodiesterasa.
WO2008134033A1 (en) * 2007-04-26 2008-11-06 The Trustees Of The University Of Pennsylvania Dna polymerase inhibitors composition and methods
US8747872B2 (en) 2007-05-02 2014-06-10 The Regents Of The University Of Michigan Nanoemulsion therapeutic compositions and methods of using the same
JP4972062B2 (ja) * 2008-03-17 2012-07-11 メディヴィル・アクチエボラーグ 抗ウイルス製剤
EP2111861A1 (de) 2008-04-21 2009-10-28 Ranbaxy Laboratories Limited Zusammensetzungen von Phosphodiesterase-IV-Hemmern
US20090291895A1 (en) * 2008-05-23 2009-11-26 Wong Scott W Methods and Compositions for the Treatment of Inflammatory Diseases
WO2011035120A2 (en) * 2009-09-17 2011-03-24 Gk Ventures, L.L.C. Therapeutic composition to treat lesions caused by herpes simplex virus
CN102049050B (zh) * 2009-11-02 2014-06-18 重庆华邦制药有限公司 抗疱疹病毒感染的药物组合物
EP2489354A1 (de) 2011-02-18 2012-08-22 Vironova AB Pharmazeutische Formulierung enthaltend B220 zur topischen Behandlung von Herpes
ITMI20111747A1 (it) * 2011-09-28 2013-03-29 Fidia Farmaceutici Composizioni farmaceutiche topiche comprendenti aciclovir
FR2983731B1 (fr) * 2011-12-07 2014-04-25 Univ Paris Descartes Emulsions topiques a base de melanges eutectiques d'anesthesiques locaux et d'acide gras
US10682370B2 (en) * 2013-03-13 2020-06-16 Nal Pharmaceutical Group Limited Topical antiviral composition containing a local anesthetic and method of making the same
CN104324039A (zh) * 2014-10-20 2015-02-04 付茜 一种治疗人身体表面脂肪瘤的药剂及使用方法
CN108853140A (zh) * 2018-07-18 2018-11-23 豆立忠 一种多药物模块软膏及其制备方法
ES2955089T3 (es) * 2018-08-17 2023-11-28 Ilko Ilac Sanayi Ve Ticaret Anonim Sirketi Composición tópica estable en fase que comprende aciclovir e hidrocortisona
AU2020292356A1 (en) 2019-06-14 2022-01-20 Propella Therapeutics, Inc. Topical acyclovir formulations and uses thereof
CN112569243A (zh) * 2019-09-30 2021-03-30 神农医药科技有限公司 制备治疗阿尔茨海默病的药物
EP4149443A4 (de) * 2020-05-11 2024-05-29 Revir, Inc. Zusammensetzungen und verfahren zur behandlung von virusinfektionen
CN112704154A (zh) * 2020-12-24 2021-04-27 中国人民解放军66399部队 一种用于治疗宠物猫疱疹病毒的营养膏
US11951082B2 (en) * 2022-08-22 2024-04-09 Ford Therapeutics, Llc Composition of chlorhexidine

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3317384A (en) * 1964-06-08 1967-05-02 Upjohn Co Treatment of topical viral infections with glucocorticoids and nucleosides
US4512978A (en) 1980-01-24 1985-04-23 Inwood Louis R Dermatological composition useful in the treatment of psoriasis
US4902678A (en) * 1982-02-12 1990-02-20 Syntex (U.S.A.) Inc. Anti-viral compositions
US4610868A (en) 1984-03-20 1986-09-09 The Liposome Company, Inc. Lipid matrix carriers for use in drug delivery systems
US5223263A (en) 1988-07-07 1993-06-29 Vical, Inc. Liponucleotide-containing liposomes
EP0594224A3 (en) * 1985-09-17 1994-07-13 Wellcome Found Therapeutic nucleosides
US5023090A (en) * 1989-08-16 1991-06-11 Levin Robert H Topical compositions containing LYCD and other topically active medicinal ingredients for the treatment of ACNE
US4942031A (en) 1988-02-23 1990-07-17 Levin Robert H Compositions containing LYCD and other topically active medicinal ingredients
WO1990006775A1 (en) * 1988-12-14 1990-06-28 Liposome Technology, Inc. A novel nonphospholipid liposome composition for sustained release of drugs
AU636255B2 (en) * 1990-11-05 1993-04-22 Arthropharm Pty Ltd Use of a topical formulation for the treatment of viral infections and neoplastic disorders
US5856364A (en) * 1991-03-01 1999-01-05 Warner Lambert Company Therapeutic antiviral-wound healing compositions and methods for preparing and using same
ES2181673T3 (es) 1991-05-01 2003-03-01 Jackson H M Found Military Med Procedimiento de tratamiento de las enfermedades respiratorias infecciosas.
IL104283A (en) * 1992-12-30 1996-12-05 Agis Ind 1983 Ltd Non-emulsion antiviral topical pharmaceutical composition comprising acyclovir an aqueous gel agent and an alkali oleate
GB9315755D0 (en) * 1993-07-30 1993-09-15 Wellcome Found Stabilized formulation
DZ1965A1 (fr) * 1995-02-06 2002-07-17 Astra Ab Composition pharmaceutique nouvelle.
GB9601544D0 (en) 1996-01-26 1996-03-27 Smithkline Beecham Plc Pharmaceuticals

Also Published As

Publication number Publication date
ZA96527B (en) 1996-08-06
CN1131034C (zh) 2003-12-17
DE69637828D1 (de) 2009-03-12
DZ1966A1 (fr) 2002-10-15
FR10C0038I1 (de) 2010-10-15
ATE421358T1 (de) 2009-02-15
NO314220B1 (no) 2003-02-17
MA23800A1 (fr) 1996-10-01
PT809498E (pt) 2004-06-30
NO973612D0 (no) 1997-08-05
WO1996024355A1 (en) 1996-08-15
EP1419803A2 (de) 2004-05-19
MY119365A (en) 2005-05-31
KR100431042B1 (ko) 2004-06-16
EP0809498A1 (de) 1997-12-03
HK1004368A1 (en) 1998-11-27
CA2211389C (en) 2007-11-20
CA2211389A1 (en) 1996-08-15
SI0809498T1 (en) 2004-12-31
FI119415B (fi) 2008-11-14
DE69632034D1 (de) 2004-05-06
EP0809498B1 (de) 2004-03-31
USRE39264E1 (en) 2006-09-05
YU7296A (sh) 1998-08-14
DK0809498T3 (da) 2004-05-10
TNSN96024A1 (fr) 2005-03-15
NO973612L (no) 1997-09-26
JP2007284452A (ja) 2007-11-01
NZ301407A (en) 1999-01-28
EP1419803A3 (de) 2004-06-09
HRP960034A2 (en) 1997-10-31
KR19980701959A (ko) 1998-06-25
DE69632034T2 (de) 2004-10-14
FR10C0038I2 (de) 2011-04-29
AU4682196A (en) 1996-08-27
FI973243A (fi) 1997-08-06
JPH11506417A (ja) 1999-06-08
TW438585B (en) 2001-06-07
YU49477B (sh) 2006-05-25
EP1419803B1 (de) 2009-01-21
FI973243A0 (fi) 1997-08-06
AR002030A1 (es) 1998-01-07
CN1179718A (zh) 1998-04-22
AU716809B2 (en) 2000-03-09
JP4260220B2 (ja) 2009-04-30
IL116913A0 (en) 1996-05-14
ES2214528T3 (es) 2004-09-16
US6337324B1 (en) 2002-01-08
SA96160590B1 (ar) 2005-10-05
DE122010000032I1 (de) 2010-10-21
HRP960034B1 (en) 2002-02-28

Similar Documents

Publication Publication Date Title
ATE262907T1 (de) Pharmazeutische zubereitung zur topischen applikation enthaltend acyclovir und hydrokortison
DE69618587D1 (de) Chinazoline und pharmazeutische zusammensetzungen
KR950703566A (ko) 티에노디아제핀 화합물 및 그의 의약 용도[thienodiazepine compound and medicinal use thereof]
AU2505795A (en) 1-arylpyrimidine derivatives and pharmaceutical use thereof
ATE269076T1 (de) Darifenacin enthaltende pharmazeutische zubereitungen
ATE221374T1 (de) Lyophilisierte stabile pharmazeutische formulierung
DE69615887D1 (de) Oral anzuwendende Arzneizubereitung enthaltend Olanzapin
AU1618697A (en) Novel compounds and pharmaceutical use thereof
DE69636783D1 (de) Verfahren und pharmazeutische zusammensetzung zur regelung der lipidkonzentration
HUP0000474A3 (en) Arylethenesulfonamide derivatives and drug composition containing the same
DE69828895D1 (de) Alpha-aryl-n-alkylnitrone sowie diese enthaltende pharmazeutische zubereitungen
HU9602104D0 (en) Novel medicines and their use
BR9602915A (pt) Medicamentos uso e formulação farmacêutica
DE69732649D1 (de) Heteroarylsulfonamidderivate und diese enthaltende pharmazeutische zubereitungen
HUP0001486A3 (en) Pharmaceutical composition for topical use cantaining nimesulide gel systems and process for preparation thereof
DE59608606D1 (de) Cyclosprorin(e) enthaltende pharmazeutische zubereitung zur oralen applikation und verfahren zu ihrer herstellung
EE04371B1 (et) Fenüülamidiini derivaadid, meetodid nende valmistamiseks ja nende kasutamine arstimitena
HUP9801158A3 (en) Imidazole derivatives and medicinal composition thereof
DE59606062D1 (de) Substituierte Benzolsulfonylharnstoffe und -thioharnstoffe, Verfahren zu ihrer Herstellung und ihrer Verwendung zur Herstellung pharmazeutischer Präparate sowie sie enthaltende pharmazeutische Präparate
IL117395A0 (en) Bicyclic compounds preparation thereof and use in pharmaceutical compositions
AU6944696A (en) Novel phenylacetic acid derivatives and medicinal composition containing the same
DE69813624D1 (de) Gemisch und pharmazeutische zubereitung enthaltend z-4-hydroxytamoxifen und cyclodextrin
AU7681498A (en) Pharmaceutical composition and use thereof
AU7352396A (en) Use of protein S-100b in medicines and medicines containing the protein S-100-b
AU7551896A (en) 1-azabicycloheptane derivatives and their pharmaceutical use